135 related articles for article (PubMed ID: 868405)
1. [Properties of C1. perfringens toxoids obtained from purified toxins].
Dmitrieva LN; Shemanova GF; Vlasova EV; Akhundova KA
Zh Mikrobiol Epidemiol Immunobiol; 1977 Apr; (4):110-4. PubMed ID: 868405
[TBL] [Abstract][Full Text] [Related]
2. [Factors modulating production of antibodies against Clostridium perfringens in mammals].
Shemanova GF; Sergeeva TI; Panteleev EI; Vlasova EV; Dmitrieva LN
Biull Eksp Biol Med; 1981 Sep; 92(9):322-5. PubMed ID: 6271303
[TBL] [Abstract][Full Text] [Related]
3. [Homogeneous Cl. perfringens alpha-anatoxin: its physicochemical and immunogenic properties].
Shemanova GF; Petrov RV; Dmitrieva LN; Panteleev EI; Drachev VA
Zh Mikrobiol Epidemiol Immunobiol; 1978 May; (5):117-22. PubMed ID: 208330
[TBL] [Abstract][Full Text] [Related]
4. [Immunogenicity and thymus-dependence of the polymerized alpha-toxoid of Clostridium perfringens].
Petrov RV; Shemanova GF; Kaverzneva ED; Kissel' VL; Panteleev EI
Biull Eksp Biol Med; 1977 Dec; 84(12):695-8. PubMed ID: 202354
[TBL] [Abstract][Full Text] [Related]
5. Alpha toxoid of Clostridium perfringens. II. Immunogenicity of the toxoid.
Ito A
Jpn J Med Sci Biol; 1970 Feb; 23(1):21-30. PubMed ID: 4317538
[No Abstract] [Full Text] [Related]
6. [Method of determinating the protective capacity of C1. perfringens toxoid].
Akhundova KA; Nenashev VP
Zh Mikrobiol Epidemiol Immunobiol; 1975 Apr; (4):43-7. PubMed ID: 176851
[TBL] [Abstract][Full Text] [Related]
7. [Immunogenic properties of Cl. perfringens anatoxins obtained from purified toxins].
Dmitrieva LN; Shemanova GF; Akhundova KA; Vlasova EV; Il'nitskaia KA
Zh Mikrobiol Epidemiol Immunobiol; 1975 Nov; (11):134-6. PubMed ID: 176848
[No Abstract] [Full Text] [Related]
8. [Immunization against gas gangrene and tetanus with sexta-anatoxin (in experiments with animals)].
Vlasova EV; Larina IA
Zh Mikrobiol Epidemiol Immunobiol; 1969 Jul; 46(7):113-6. PubMed ID: 4315881
[No Abstract] [Full Text] [Related]
9. Comparative study on the immunogenic properties of Clostridium perfringens type A toxoid.
Shemanova GF; Vlasova EV; Dmitrieva LN; Trapezov EV; Gorbacheva LD
J Hyg Epidemiol Microbiol Immunol; 1986; 30(3):323-9. PubMed ID: 2877025
[TBL] [Abstract][Full Text] [Related]
10. Toxoid of Clostridium botulinum type F: purification and immunogenicity studies.
Hatheway CL
Appl Environ Microbiol; 1976 Feb; 31(2):234-42. PubMed ID: 793522
[TBL] [Abstract][Full Text] [Related]
11. [A comparative study of the antigenic and immunogenic properties of the anatoxin of Cl. perfringens, concentrated and purified by various methods].
Larina IA; Samsonova VS; Volkova ZM
Zh Mikrobiol Epidemiol Immunobiol; 1968 Apr; 45(4):86-9. PubMed ID: 4309741
[No Abstract] [Full Text] [Related]
12. [Study of the interrelationship between the content of immunizing units and the immunogenicity of C1. perfringens anatoxins].
Nenashev VP; Akhundova KA
Zh Mikrobiol Epidemiol Immunobiol; 1975 Aug; (8):93-6. PubMed ID: 173119
[TBL] [Abstract][Full Text] [Related]
13. [Immunogenic properties of Clostridium perfringens type A anatheta-hemolysin].
Sergeeva TI; Dolgikh MS; Blagoveshchenskiĭ VA
Zh Mikrobiol Epidemiol Immunobiol; 1981 Nov; (11):71-5. PubMed ID: 6275640
[TBL] [Abstract][Full Text] [Related]
14. [Characteristics of the immunologic response of animals to Clostridium perfringens anatoxin].
Petrov RV; Shemanova GF; Panteleev EI; Dmitrieva LN; Vlasova EV
Zh Mikrobiol Epidemiol Immunobiol; 1977 May; (5):71-4. PubMed ID: 197752
[TBL] [Abstract][Full Text] [Related]
15. The detection of the factor lowering the immunogenicity of toxoid of Clostridium perfringens type A.
Shemanova GF; Vlasova EV; Sergeeva TI; Panteleyev EI
Arch Roum Pathol Exp Microbiol; 1981; 40(4):299-303. PubMed ID: 6280638
[No Abstract] [Full Text] [Related]
16. Development of a purified cholera toxoid. II. Preparation of a stable, antigenic toxoid by reaction of purified toxin with glutaraldehyde.
Rappaport RS; Bonde G; McCann T; Rubin BA; Tint H
Infect Immun; 1974 Feb; 9(2):304-17. PubMed ID: 4205946
[TBL] [Abstract][Full Text] [Related]
17. [Protective properties of theta-hemolysin obtained by affinity chromatography].
Efimova MG; Blagoveshchenskiĭ VA; Khatuntseva BV
Zh Mikrobiol Epidemiol Immunobiol; 1982 Dec; (12):87-92. PubMed ID: 6297191
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of purified Habu snake-venom toxoid in guinea pigs and monkeys with special reference to HR1 component.
Sadahiro S; Omori-Satoh T; Yamauchi K; Kondo S; Ishida S; Murata R
Jpn J Med Sci Biol; 1981 Aug; 34(4):213-30. PubMed ID: 6798252
[TBL] [Abstract][Full Text] [Related]
19. Development of a purified cholera toxoid. III. Refinements in purification of toxin and methods for the determination of residual somatic antigen.
Rappaport RS; Pierzchala WA; Bonde G; McCann T; Rubin BA
Infect Immun; 1976 Sep; 14(3):687-93. PubMed ID: 823117
[TBL] [Abstract][Full Text] [Related]
20. [Toxin formation by Cl. perfringens type E].
Zemlianitskaia EP; Matveev KI; Tsurikov FF
Zh Mikrobiol Epidemiol Immunobiol; 1966 Jul; 43(7):86-90. PubMed ID: 4307060
[No Abstract] [Full Text] [Related]
[Next] [New Search]
